PharMerica Corp. Reaches New 12-Month High at $25.72 (PMC)
PharMerica Corp. (NYSE:PMC)’s share price reached a new 52-week high during trading on Friday, StockRatingsNetwork.com reports. The stock traded as high as $25.72 and last traded at $25.49, with a volume of 1,384,368 shares traded. The stock had previously closed at $20.39.
A number of analysts have recently weighed in on PMC shares. Analysts at Barclays raised their price target on shares of PharMerica Corp. from $14.00 to $16.00 in a research note to investors on Wednesday. They now have an “underweight” rating on the stock. Finally, analysts at UBS AG raised their price target on shares of PharMerica Corp. from $15.00 to $19.00 in a research note to investors on Wednesday, November 6th. They now have a “neutral” rating on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $16.80.
PharMerica Corp. has a one year low of $11.84 and a one year high of $22.85. The stock has a 50-day moving average of $20.94 and a 200-day moving average of $15.95. The company has a market cap of $762.5 million and a price-to-earnings ratio of 33.43.
PharMerica Corp. (NYSE:PMC) last announced its earnings results on Tuesday, November 5th. The company reported $0.49 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.32 by $0.17. The company had revenue of $442.00 million for the quarter, compared to the consensus estimate of $398.02 million. During the same quarter in the prior year, the company posted $0.33 earnings per share. The company’s quarterly revenue was down 1.2% on a year-over-year basis. On average, analysts predict that PharMerica Corp. will post $1.79 earnings per share for the current fiscal year.
PharMerica Corporation is an institutional pharmacy services company, which services healthcare facilities and provides management pharmacy services to hospitals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.